Opioids Should Be Avoided for Individuals with Migraine Who Come to Emergency Department

New research supports avoiding the use of opioids for patients who come to the emergency department (ED) with migraine. The study, which was presented at the American Headache Society (AHS) 59th Scientific Meeting in June 2017, shows that patients who arrived in the ED with acute migraine and received intravenous prochlorperazine were twice as likely to have headache relief within 2 hours as those who received opioids. Continue Reading


Curelator Presents Misconceptions on Migraine Triggers

Curelator Headache presented new data at the American Headache Society (AHS) 59th Scientific Meeting in June 2017 that shows some common migraine triggers may be misunderstood.

One presentation at the meeting in Boston concentrated on the results of 488 users of Curelator, a digital platform that allows individuals with migraine to track factors that may have an effect on their risk of a migraine attack. Continue Reading